Foram relatadas várias intervenções capazes de reduzir o risco de câncer colorretal.
Aspirina
Vários estudos relataram que o uso de aspirina está associado à redução do risco de câncer colorretal.[81]Shami JJP, Zhao J, Pathadka S, et al. Safety and effectiveness of low-dose aspirin for the prevention of gastrointestinal cancer in adults without atherosclerotic cardiovascular disease: a population-based cohort study. BMJ Open. 2022 Feb 4;12(2):e050510.
https://bmjopen.bmj.com/content/12/2/e050510
http://www.ncbi.nlm.nih.gov/pubmed/35121597?tool=bestpractice.com
[82]Sikavi DR, Wang K, Ma W, et al. Aspirin use and incidence of colorectal cancer according to lifestyle risk. JAMA Oncol. 2024 Oct 1;10(10):1354-61.
http://www.ncbi.nlm.nih.gov/pubmed/39088221?tool=bestpractice.com
[83]Lloyd KE, Hall LH, King N, et al. Aspirin use for cancer prevention: a systematic review of public, patient and healthcare provider attitudes and adherence behaviours. Prev Med. 2022 Jan;154:106872.
https://www.sciencedirect.com/science/article/pii/S009174352100445X?via%3Dihub
http://www.ncbi.nlm.nih.gov/pubmed/34762964?tool=bestpractice.com
[84]Guo CG, Ma W, Drew DA, et al. Aspirin use and risk of colorectal cancer among older adults. JAMA Oncol. 2021 Mar 1;7(3):428-35.
https://www.doi.org/10.1001/jamaoncol.2020.7338
http://www.ncbi.nlm.nih.gov/pubmed/33475710?tool=bestpractice.com
Um estudo de coorte relatou uma redução absoluta maior no risco de câncer colorretal entre indivíduos com estilos de vida menos saudáveis.[82]Sikavi DR, Wang K, Ma W, et al. Aspirin use and incidence of colorectal cancer according to lifestyle risk. JAMA Oncol. 2024 Oct 1;10(10):1354-61.
http://www.ncbi.nlm.nih.gov/pubmed/39088221?tool=bestpractice.com
Uma análise combinada de dois grandes estudos de coorte dos EUA constatou que o uso de aspirina reduziu o risco de câncer colorretal, se iniciado antes dos 70 anos de idade e continuado além dos 70 anos, mas o início em idade mais avançada não reduziu o risco.[84]Guo CG, Ma W, Drew DA, et al. Aspirin use and risk of colorectal cancer among older adults. JAMA Oncol. 2021 Mar 1;7(3):428-35.
https://www.doi.org/10.1001/jamaoncol.2020.7338
http://www.ncbi.nlm.nih.gov/pubmed/33475710?tool=bestpractice.com
As diretrizes diferem em relação à aspirina como medicamento preventivo para câncer colorretal. A US Preventive Services Task Force publicou uma revisão sistemática e orientações sobre o uso de aspirina para prevenir doença cardiovascular e câncer colorretal. A aspirina não é mais recomendada como tratamento preventivo para câncer colorretal, devido à ausência de evidências de alta qualidade que comprovem que ela reduz a incidência de câncer colorretal ou a mortalidade.[41]National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: colorectal cancer screening [internet publication].
https://www.nccn.org/professionals/physician_gls/default.aspx
[85]Guirguis-Blake JM, Evans CV, Perdue LA, et al. Aspirin use to prevent cardiovascular disease and colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2022 Apr 26;327(16):1585-97.
https://jamanetwork.com/journals/jama/fullarticle/2791401
http://www.ncbi.nlm.nih.gov/pubmed/35471507?tool=bestpractice.com
O American College of Gastroenterologists recomenda aspirina em baixa dose em adultos com idades entre 50-69 anos com risco de doença cardiovascular de ≥10% nos próximos 10 anos, que não apresentam aumento do risco de sangramento e estão dispostos a tomar aspirina por pelo menos 10 anos para reduzir o risco de câncer colorretal.[86]Shaukat A, Kahi CJ, Burke CA, et al. ACG clinical guidelines: colorectal cancer screening 2021. Am J Gastroenterol. 2021 Mar 1;116(3):458-79.
https://journals.lww.com/ajg/Fulltext/2021/03000/ACG_Clinical_Guidelines__Colorectal_Cancer.14.aspx
http://www.ncbi.nlm.nih.gov/pubmed/33657038?tool=bestpractice.com
Pesquisas relacionadas à utilidade clínica da aspirina para a prevenção primária do câncer colorretal em populações de pacientes de risco médio e elevado estão em andamento.[84]Guo CG, Ma W, Drew DA, et al. Aspirin use and risk of colorectal cancer among older adults. JAMA Oncol. 2021 Mar 1;7(3):428-35.
https://www.doi.org/10.1001/jamaoncol.2020.7338
http://www.ncbi.nlm.nih.gov/pubmed/33475710?tool=bestpractice.com
[87]Cook NR, Lee IM, Zhang SM, et al. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med. 2013 Jul 16;159(2):77-85.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713531
http://www.ncbi.nlm.nih.gov/pubmed/23856681?tool=bestpractice.com
[88]Emilsson L, Holme Ø, Bretthauer M, et al. Systematic review with meta-analysis: the comparative effectiveness of aspirin vs. screening for colorectal cancer prevention. Aliment Pharmacol Ther. 2017 Jan;45(2):193-204.
https://www.doi.org/10.1111/apt.13857
http://www.ncbi.nlm.nih.gov/pubmed/27859394?tool=bestpractice.com
[89]Giorli G, Rouette J, Yin H, et al. Prediagnostic use of low-dose aspirin and risk of incident metastasis and all-cause mortality among patients with colorectal cancer. Br J Clin Pharmacol. 2020 Nov;86(11):2266-73.
https://www.doi.org/10.1111/bcp.14329
http://www.ncbi.nlm.nih.gov/pubmed/32352592?tool=bestpractice.com
[90]Nishihara R, Lochhead P, Kuchiba A, et al. Aspirin use and risk of colorectal cancer according to BRAF mutation status. JAMA. 2013 Jun 26;309(24):2563-71.
https://www.doi.org/10.1001/jama.2013.6599
http://www.ncbi.nlm.nih.gov/pubmed/23800934?tool=bestpractice.com
A aspirina pode ajudar a prevenir o câncer colorretal em pacientes com síndrome de Lynch. As diretrizes recomendam aspirina diária (tomada por mais de 2 anos) para prevenir o câncer colorretal em pessoas com síndrome de Lynch (câncer colorretal hereditário não polipose).[41]National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: colorectal cancer screening [internet publication].
https://www.nccn.org/professionals/physician_gls/default.aspx
[91]National Institute for Health and Care Excellence. Colorectal cancer. Dec 2021 [internet publication].
https://www.nice.org.uk/guidance/ng151
[92]Burn J, Sheth H, Elliott F, et al. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial. Lancet. 2020 Jun 13;395(10240):1855-63.
https://www.doi.org/10.1016/S0140-6736(20)30366-4
http://www.ncbi.nlm.nih.gov/pubmed/32534647?tool=bestpractice.com
[93]National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: genetic/familial high-risk assessment: colorectal, endometrial, and gastric [internet publication].
https://www.nccn.org/guidelines/category_2
Medicamentos anti-inflamatórios não esteroidais
Uma revisão sistemática, incluindo mais de um milhão de pessoas na análise, revelou que o uso regular de AINEs que não são aspirina reduziu o câncer colorretal em pessoas com 40 anos ou mais.[94]Tomić T, Domínguez-López S, Barrios-Rodríguez R. Non-aspirin non-steroidal anti-inflammatory drugs in prevention of colorectal cancer in people aged 40 or older: a systematic review and meta-analysis. Cancer Epidemiol. 2019 Feb;58:52-62.
http://www.ncbi.nlm.nih.gov/pubmed/30472477?tool=bestpractice.com
Efeitos protetores significativos foram encontrados para mulheres, altas doses, câncer de cólon distal e pessoas brancas.[94]Tomić T, Domínguez-López S, Barrios-Rodríguez R. Non-aspirin non-steroidal anti-inflammatory drugs in prevention of colorectal cancer in people aged 40 or older: a systematic review and meta-analysis. Cancer Epidemiol. 2019 Feb;58:52-62.
http://www.ncbi.nlm.nih.gov/pubmed/30472477?tool=bestpractice.com
AINEs não aspirina não são recomendados para a prevenção de neoplasias colorretais.[95]Liang PS, Shaukat A, Crockett SD. AGA clinical practice update on chemoprevention for colorectal neoplasia: expert review. Clin Gastroenterol Hepatol. 2021 Jul;19(7):1327-36.
https://www.cghjournal.org/article/S1542-3565(21)00148-8/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/33581359?tool=bestpractice.com
Ensaios clínicos randomizados e controlados mostraram que os inibidores da ciclo-oxigenase (COX-2) reduzem a taxa de recorrência de adenoma, o que pode ter implicações para um risco de câncer subsequente.[96]Rostom A, Dubé C, Lewin G, et al. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med. 2007 Mar 6;146(5):376-89.
https://www.acpjournals.org/doi/full/10.7326/0003-4819-146-5-200703060-00010?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org
http://www.ncbi.nlm.nih.gov/pubmed/17339623?tool=bestpractice.com
Suplementos alimentares
Dietas saudáveis à base de plantas, ricas em cereais integrais, frutas e vegetais, podem reduzir a incidência de câncer colorretal, especialmente o câncer colorretal do tipo selvagem relacionado a KRAS. Dietas ricas em grãos refinados e açúcares devem ser evitadas.[97]Kim J, Boushey CJ, Wilkens LR, et al. Plant-based dietary patterns defined by a priori indices and colorectal cancer risk by sex and race/ethnicity: the multiethnic cohort study. BMC Med. 2022 Nov 29;20(1):430.
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-022-02623-7
http://www.ncbi.nlm.nih.gov/pubmed/36443779?tool=bestpractice.com
[98]Liu F, Lv Y, Peng Y, et al. Plant-based dietary patterns, genetic predisposition and risk of colorectal cancer: a prospective study from the UK Biobank. J Transl Med. 2023 Sep 27;21(1):669.
https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04522-8
http://www.ncbi.nlm.nih.gov/pubmed/37759216?tool=bestpractice.com
[99]Wang F, Ugai T, Haruki K, et al. Healthy and unhealthy plant-based diets in relation to the incidence of colorectal cancer overall and by molecular subtypes. Clin Transl Med. 2022 Aug;12(8):e893.
https://onlinelibrary.wiley.com/doi/10.1002/ctm2.893
http://www.ncbi.nlm.nih.gov/pubmed/35998061?tool=bestpractice.com
Uma metanálise de resposta à dose revelou que a ingestão de vitamina B2 está inversamente associada ao risco de câncer colorretal.[100]Ben S, Du M, Ma G, et al. Vitamin B2 intake reduces the risk for colorectal cancer: a dose-response analysis. Eur J Nutr. 2019 Jun;58(4):1591-602.
http://www.ncbi.nlm.nih.gov/pubmed/29744609?tool=bestpractice.com
Uma revisão sistemática e uma metanálise relataram que a alta ingestão de vitamina B9 pode ser um fator de proteção contra o câncer de cólon, especialmente em indivíduos com consumo moderado a alto de bebidas alcoólicas; são necessários estudos adicionais para confirmar esse achado.[101]Fu H, He J, Li C, et al. Folate intake and risk of colorectal cancer: a systematic review and up-to-date meta-analysis of prospective studies. Eur J Cancer Prev. 2023 Mar 1;32(2):103-12.
http://www.ncbi.nlm.nih.gov/pubmed/35579178?tool=bestpractice.com
A American Gastroenterological Association (AGA) não recomenda o uso de vitamina B9 para prevenir neoplasias colorretais.[95]Liang PS, Shaukat A, Crockett SD. AGA clinical practice update on chemoprevention for colorectal neoplasia: expert review. Clin Gastroenterol Hepatol. 2021 Jul;19(7):1327-36.
https://www.cghjournal.org/article/S1542-3565(21)00148-8/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/33581359?tool=bestpractice.com
O consumo de peixes e ácidos graxos poli-insaturados n-3 de cadeia longa em níveis recomendados pela Organização Mundial da Saúde tem sido associado a um risco reduzido de câncer colorretal.[102]Aglago EK, Huybrechts I, Murphy N, et al. Consumption of fish and long-chain n-3 polyunsaturated fatty acids is associated with reduced risk of colorectal cancer in a large European cohort. Clin Gastroenterol Hepatol. 2020 Mar;18(3):654-66.e6.
https://www.doi.org/10.1016/j.cgh.2019.06.031
http://www.ncbi.nlm.nih.gov/pubmed/31252190?tool=bestpractice.com
[103]Li L, Wang D, He N, et al. Effects of polyunsaturated fatty acids on colorectal cancer patients: a meta-analysis of randomized controlled trials. Nutr Cancer. 2023;75(2):627-39.
https://www.tandfonline.com/doi/full/10.1080/01635581.2022.2145319#d1e303
http://www.ncbi.nlm.nih.gov/pubmed/36372063?tool=bestpractice.com
Há uma controvérsia em relação ao fato de que a suplementação de cálcio e vitamina D pode prevenir câncer colorretal.[104]Cruz-Pierard SM, Nestares T, Amaro-Gahete FJ. Vitamin D and calcium as key potential factors related to colorectal cancer prevention and treatment: a systematic review. Nutrients. 2022 Nov 21;14(22):4934.
https://www.mdpi.com/2072-6643/14/22/4934
http://www.ncbi.nlm.nih.gov/pubmed/36432621?tool=bestpractice.com
[105]Emami MH, Salehi M, Hassanzadeh Keshteli A, et al. Calcium and dairy products in the chemoprevention of colorectal adenomas: a systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2022;62(26):7168-83.
http://www.ncbi.nlm.nih.gov/pubmed/33951958?tool=bestpractice.com
[106]Lopez-Caleya JF, Ortega-Valín L, Fernández-Villa T, et al. The role of calcium and vitamin D dietary intake on risk of colorectal cancer: systematic review and meta-analysis of case-control studies. Cancer Causes Control. 2022 Feb;33(2):167-82.
http://www.ncbi.nlm.nih.gov/pubmed/34708323?tool=bestpractice.com
[107]Ma Y, You W, Cao Y, et al. Chemoprevention of colorectal cancer in general population and high-risk population: a systematic review and network meta-analysis. Chin Med J (Engl). 2023 Apr 5;136(7):788-98.
https://journals.lww.com/cmj/fulltext/2023/04050/chemoprevention_of_colorectal_cancer_in_general.4.aspx
http://www.ncbi.nlm.nih.gov/pubmed/37027286?tool=bestpractice.com
[108]Emmanouilidou G, Kalopitas G, Bakaloudi DR, et al. Vitamin D as a chemopreventive agent in colorectal neoplasms. a systematic review and meta-analysis of randomized controlled trials. Pharmacol Ther. 2022 Sep;237:108252.
http://www.ncbi.nlm.nih.gov/pubmed/35926664?tool=bestpractice.com
Fontes naturais, como laticínios, podem ser mais benéficas do que os suplementos.[105]Emami MH, Salehi M, Hassanzadeh Keshteli A, et al. Calcium and dairy products in the chemoprevention of colorectal adenomas: a systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2022;62(26):7168-83.
http://www.ncbi.nlm.nih.gov/pubmed/33951958?tool=bestpractice.com
Uma revisão sistemática e metanálise sugerem que uma ingestão alimentar maior de vitamina D pode ser eficaz para reduzir o risco de câncer colorretal.[106]Lopez-Caleya JF, Ortega-Valín L, Fernández-Villa T, et al. The role of calcium and vitamin D dietary intake on risk of colorectal cancer: systematic review and meta-analysis of case-control studies. Cancer Causes Control. 2022 Feb;33(2):167-82.
http://www.ncbi.nlm.nih.gov/pubmed/34708323?tool=bestpractice.com
A AGA não recomenda aos médicos a prescrição de cálcio ou vitamina D (combinados ou isolados) para prevenir neoplasias colorretais.[95]Liang PS, Shaukat A, Crockett SD. AGA clinical practice update on chemoprevention for colorectal neoplasia: expert review. Clin Gastroenterol Hepatol. 2021 Jul;19(7):1327-36.
https://www.cghjournal.org/article/S1542-3565(21)00148-8/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/33581359?tool=bestpractice.com
Como níveis baixos de vitamina D foram associados ao aumento do risco de câncer, a National Comprehensive Cancer Network sugere que a suplementação em indivíduos com deficiência dessa vitamina pode ser benéfica. Ela também recomenda que, em geral, os nutrientes devem ser obtidos de fontes alimentares naturais, em vez de suplementos alimentares exclusivamente.[41]National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: colorectal cancer screening [internet publication].
https://www.nccn.org/professionals/physician_gls/default.aspx
Polipectomia colonoscópica
A remoção colonoscópica dos pólipos adenomatosos impede óbitos decorrentes de câncer colorretal.[109]Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012 Feb 23;366(8):687-96.
https://www.nejm.org/doi/full/10.1056/NEJMoa1100370
http://www.ncbi.nlm.nih.gov/pubmed/22356322?tool=bestpractice.com
Abandono do hábito de fumar
O tabagismo em longo prazo está associado ao aumento da incidência de câncer colorretal e mortalidade.[7]GBD 2019 Colorectal Cancer Collaborators. Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022 Jul;7(7):627-47.
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00044-9/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/35397795?tool=bestpractice.com
[47]Botteri E, Borroni E, Sloan EK, et al. Smoking and colorectal cancer risk, overall and by molecular subtypes: a meta-analysis. Am J Gastroenterol. 2020 Dec;115(12):1940-9.
http://www.ncbi.nlm.nih.gov/pubmed/32773458?tool=bestpractice.com
A redução do risco é observada com o abandono precoce do hábito de fumar; aconselhar o paciente a abandono do hábito de fumar é fortemente recomendado.[41]National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: colorectal cancer screening [internet publication].
https://www.nccn.org/professionals/physician_gls/default.aspx
[42]Chao A, Thun MJ, Jacobs EJ, et al. Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J Natl Cancer Inst. 2000 Dec 6;92(23):1888-96.
https://academic.oup.com/jnci/article/92/23/1888/2906035
http://www.ncbi.nlm.nih.gov/pubmed/11106680?tool=bestpractice.com
[43]Hannan LM, Jacobs EJ, Thun MJ. The association between cigarette smoking and risk of colorectal cancer in a large prospective cohort from the United States. Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3362-7.
https://aacrjournals.org/cebp/article/18/12/3362/67454/The-Association-between-Cigarette-Smoking-and-Risk
http://www.ncbi.nlm.nih.gov/pubmed/19959683?tool=bestpractice.com
Redução de bebidas alcoólicas
O consumo moderado a excessivo de bebidas alcoólicas foi associado ao aumento do risco de câncer colorretal, o que sugere que a redução do consumo de bebidas alcoólicas pode ser benéfica nesse grupo de pacientes.[41]National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: colorectal cancer screening [internet publication].
https://www.nccn.org/professionals/physician_gls/default.aspx
[45]O'Sullivan DE, Sutherland RL, Town S, et al. Risk factors for early-onset colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2022 Jun;20(6):1229-40.e5.
https://www.cghjournal.org/article/S1542-3565(21)00087-2/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/33524598?tool=bestpractice.com
[48]Rossi M, Jahanzaib Anwar M, Usman A, et al. Colorectal cancer and alcohol consumption-populations to molecules. Cancers (Basel). 2018 Jan 30;10(2):38.
https://www.mdpi.com/2072-6694/10/2/38
http://www.ncbi.nlm.nih.gov/pubmed/29385712?tool=bestpractice.com
Uma metanálise de 61 estudos independentes (27 estudos de coorte e 34 estudos tipo caso-controle) analisou a associação entre o consumo de bebidas alcoólicas (leve, moderado ou excessivo) e o risco de câncer colorretal. Em comparação com indivíduos que não bebem ou que bebem ocasionalmente, o consumo moderado (2-3 doses/dia, equivalentes a 12.6 a 49.9 gramas de etanol/dia) e o consumo excessivo (≥4 doses/dia, equivalentes a ≥50 gramas de etanol/dia) foram associados com o aumento do risco de câncer colorretal, de 21% e 52%, respectivamente.[44]Fedirko V, Tramacere I, Bagnardi V, et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol. 2011 Sep;22(9):1958-72.
https://www.annalsofoncology.org/article/S0923-7534(19)38342-5/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/21307158?tool=bestpractice.com
Redução no consumo de carne vermelha e processada
Como a alta ingestão de carne vermelha e processada está associada ao aumento do risco de câncer colorretal, uma redução na ingestão pode diminuir o risco de desenvolver câncer colorretal.[33]Farvid MS, Sidahmed E, Spence ND, et al. Consumption of red meat and processed meat and cancer incidence: a systematic review and meta-analysis of prospective studies. Eur J Epidemiol. 2021 Sep;36(9):937-51.
http://www.ncbi.nlm.nih.gov/pubmed/34455534?tool=bestpractice.com
[34]Bouvard V, Loomis D, Guyton KZ, et al. Carcinogenicity of consumption of red and processed meat. Lancet Oncol. 2015 Dec;16(16):1599-600.
http://www.ncbi.nlm.nih.gov/pubmed/26514947?tool=bestpractice.com
[35]Hammerling U, Bergman Laurila J, Grafström R, et al. Consumption of red/processed meat and colorectal carcinoma: possible mechanisms underlying the significant association. Crit Rev Food Sci Nutr. 2016;56(4):614-34.
http://www.ncbi.nlm.nih.gov/pubmed/25849747?tool=bestpractice.com